2.2 Caffeine in liver fibrosis Liver fibrosis is a pathophysiological process that refers to the abnormal proliferation of connective tissues in the liver induced by various pathogenic factors, including viral hepatitis, alcohol, fatty liver, and autoimmune diseases ( 4 ), and thioacetamide (TAA), and protective effects of filtered coffee were found in most of the published studies ( 4 -induced hepatic damage in mice through its antioxidant capacities ( 4 -induced liver fibrosis but also significantly increased AST/ALT levels, thereby exacerbating CCl 4 -induced hepatotoxicity ( Persistent inflammatory factors stimulate HSCs in the liver to secrete fibrotic factors that increase extracellular matrix (ECM) formation and ultimately lead to liver fibrosis ( 4 , DMN, and TAA-induced hepatic fibrosis, coffee and caffeine intake reduced transforming growth factor- (TGF-) levels and thus inhibited HSC activation and proliferation ( in vivo studies have shown that the anti-fibrosis properties of caffeine converge with a reduction in HSC activation and proliferation ( HSCs are deemed the main effector cells in liver fibrosis (Figure 2

Future research should investigate how lifestyle factors (such as diet, exercise, and smoking) and environmental exposures (like pollution and UV radiation) influence oxidative stress and the effectiveness of antioxidants
Mitochondrial-derived peptides in energy metabolism
Biological consequences of thiol-mediated amoxicillin transformation are exemplified by a reduced bacteriostatic action and a lower capacity of thiol-treated amoxicillin to form protein adducts